We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.71%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$25.1B
AUM Growth
+$248M
(+1%)
Cap. Flow
-$713M
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
18.42%
Holding
1,996
New
165
Increased
551
Reduced
491
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$213M |
| 2 |
Campbell Soup
CPB
|
+$174M |
| 3 |
Dentsply Sirona
XRAY
|
+$111M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$110M |
| 5 |
TJX Companies
TJX
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Oracle
ORCL
|
+$162M |
| 3 |
Union Pacific
UNP
|
+$140M |
| 4 |
Wells Fargo
WFC
|
+$118M |
| 5 |
Nike
NKE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.54% |
| 2 | Technology | 12.85% |
| 3 | Healthcare | 12.82% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Consumer Staples | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
John B. Sanfilippo & Son
JBSS
$949M
| $1.08M | ﹤0.01% |
16,000
+1,300
| +9% | +$83.3K |
|
602
General Mills
GIS
$19.2B
| $1.07M | ﹤0.01% |
20,636
+4,353
| +27% | +$239K |
|
603
Peoples Bancorp
PEBO
$1.45B
| $1.06M | ﹤0.01% |
31,700
| – | – |
|
604
TE Connectivity
TEL
$58.8B
| $1.06M | ﹤0.01% |
12,740
+1,142
| +10% | +$91.8K |
|
605
Duke Energy
DUK
$102B
| $1.06M | ﹤0.01% |
12,578
+142
| +1% | +$12.2K |
|
|
MPV
606
Barings Participation Investors
MPV
$168M
| $1.06M | ﹤0.01% |
73,159
-17,000
| -19% | -$245K |
|
|
MON
607
DELISTED
Monsanto Co
MON
| $1.05M | ﹤0.01% |
8,799
+688
| +8% | +$81K |
|
608
Marcus Corp
MCS
$732M
| $1.04M | ﹤0.01% |
37,700
-500
| -1% | -$13.4K |
|
609
Pathward Financial
CASH
$1.81B
| $1.04M | ﹤0.01% |
39,900
-8,400
| -17% | -$217K |
|
610
Plains GP Holdings
PAGP
$5.23B
| $1.04M | ﹤0.01% |
47,630
+19,882
| +72% | +$472K |
|
|
CUTR
611
DELISTED
Cutera, Inc.
CUTR
| $1.04M | ﹤0.01% |
25,200
| – | – |
|
612
Avanos Medical
AVNS
$1.17B
| $1.03M | ﹤0.01% |
22,947
| – | – |
|
|
MXIM
613
DELISTED
Maxim Integrated Products
MXIM
| $1.03M | ﹤0.01% |
21,635
| – | – |
|
|
MYOK
614
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.03M | ﹤0.01% |
+24,078
| New | +$768K |
|
615
Stride
LRN
$3.69B
| $1.03M | ﹤0.01% |
57,700
+10,500
| +22% | +$186K |
|
616
Capital One
COF
$124B
| $1.02M | ﹤0.01% |
12,111
-77,369
| -86% | -$6.38M |
|
617
Martin Marietta Materials
MLM
$33.6B
| $1.02M | ﹤0.01% |
4,961
+4,938
| +21,470% | +$1.04M |
|
|
KE
618
Kimball Electronics
KE
$598M
| $1.02M | ﹤0.01% |
47,200
| – | – |
|
619
A.O. Smith
AOS
$8.38B
| $1.02M | ﹤0.01% |
17,171
+4,359
| +34% | +$244K |
|
620
Cencora
COR
$60.3B
| $1.02M | ﹤0.01% |
12,320
+1,220
| +11% | +$104K |
|
621
FedEx
FDX
$74.5B
| $1.02M | ﹤0.01% |
4,517
-389
| -8% | -$82.8K |
|
622
Sempra
SRE
$60.8B
| $1.02M | ﹤0.01% |
17,852
+6,320
| +55% | +$366K |
|
623
Cigna
CI
$76.6B
| $1.01M | ﹤0.01% |
5,387
+4,680
| +662% | +$833K |
|
624
Carlyle Group
CG
$16.3B
| $1M | ﹤0.01% |
42,539
+39,539
| +1,318% | +$843K |
|
625
Kinsale Capital Group
KNSL
$7.95B
| $1M | ﹤0.01% |
+23,200
| New | +$904K |
|
Similar funds
Bessemer Group's Q3 2017 Portfolio in Review
As of Q3 2017, Bessemer Group held 1,996 positions worth $25.1B, up 1% from $24.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bessemer Group's Q3 2017 filing shows 165 new, 551 increased, 491 reduced and 200 closed positions. Its largest new stake was VanEck Gold Miners ETF: 9,205,600 shares worth $211M. The largest sale was Allergan plc, an estimated $200M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- Bessemer Group's largest Q3 2017 buy was VanEck Gold Miners ETF: 9,205,600 shares worth $211M.
- Bessemer Group added most to Campbell Soup in Q3 2017, an estimated $174M increase.
- Bessemer Group's biggest Q3 2017 reduction was Allergan plc, cutting an estimated $200M.
- Bessemer Group fully exited iShares MSCI Brazil ETF in Q3 2017, selling an estimated $10.6M.
- Bessemer Group's ten largest holdings make up 18% of its $25.1B portfolio in Q3 2017.
- Bessemer Group opened 165 new positions and closed 200 in Q3 2017.
- Bessemer Group's portfolio value rose 1% quarter-over-quarter to $25.1B.
Based on Bessemer Group's 13F filing for Q3 2017, filed 3 Nov 2017.